BioInformant

Your Global Leader in Stem Cell Market Research

MENUMENU
  • Blog
    • Interviews
  • News
  • Stem Cells
    • iPS Cells
    • MSCs
    • HSCs
    • Adipose SCs
    • Neural Stem Cells
  • Exosomes
  • CAR-T
  • Cord Blood
  • Shop
    • Products
    • Submit PR
    • Advertise
  • About
    • Testimonials
    • Story
    • Guarantee
    • Contact
  • Home
  • Blog
    • Stem Cells
      • HSCs
      • iPS Cells
      • MSCs
      • Neural Stem Cells
      • Adipose SCs
    • Exosomes
    • Cell Therapy
      • CAR-T
    • Cord Blood
    • Stem Cell News
    • Interviews
  • COVID-19
  • Shop
  • Submit PR
  • Company
    • Advertise
    • Testimonials
    • Story
    • Job Posts
    • Guarantee
    • Privacy Policy
    • Contact
Home » Stem Cells » iPS Cells » Page 51

3 Bullet Thursday – Stem Cells for HIV, ESCs vs. iPSCs, and Twitter as a News Source

October 29, 2015 By Cade Hildreth (CEO) Leave a Comment

3 Bullet Thursday - Oct 29, 2015

Stay alert to the latest and greatest on stem cells.  Enjoy this week’s “3 Bullet Thursday,” a weekly post that we do to update you on interesting and important events within the world of stem cells.


 

1. Wow, the world’s first clinical trial to treat HIV patients using umbilical cord blood transplants is set to start in Spain. Plans for the trial were announced last week at a haematology conference in Valencia by Spain’s National Organisation of Transplants (ONT).

 

2. Talk about a controversial topic! A new study published in Nature Biotechnology announces embryonic stem cells and induced pluripotent stem cells to be “equal.” More specifically, the authors state, “We conclude that hESCs and hiPSCs are molecularly and functionally equivalent.”

 

3. In a July 2013 USA Today article, Rem Rieder discusses how Twitter is a news pipeline for more than 200 million active users, often ‘breaking’ news before it’s actually news. Want to know where to get your morning stem cell news? These are the top 15 accounts breaking stem cell news on Twitter.

 

Happy Thursday!

 


Want to get this fun weekly update?  Join below and we’ll keep you in the loop, starting next week.

Filed Under: Cord Blood, iPS Cells, Stem Cells Tagged With: 3 bullet thursday, cord blood, embryonic stem cells, HIV, induced pluripotent stem cells, stem cells, twitter

3 Bullet Thursday – Stem Cells for Bioprinting, Fertility, & Replacement Organs (Oct 22, 2015)

October 22, 2015 By Cade Hildreth (CEO) Leave a Comment

3 Bullet Thursday - Stem Cells (Oct 22, 2015)

Stay alert to the latest and greatest on stem cells.  Enjoy this week’s “3 Bullet Thursday,” a weekly post that we do to update you on interesting and important events within the world of stem cells.


1. RoosterBio has released the world’s first ever ready-to-print (RTP) stem cell product, “thaw and use” human mesenchymal stem cells (hMSCs). This advance will make standardized cells accessible for rapid 3D bioprinting and tissue engineering. Totally incredible.

2. Scientists from Egypt’s Mansoura Medical School have successfully reversed infertility from cancer by directly injecting stem cells into the ovaries.

3. Will we eventually grow replacements organs using our own stem cells? It’s possible, as two research teams released news of growing kidney structures from stem cells within the past month.

First, an American team lead by Dr. Ryuji Morizane published findings in Nature Biotechnology that they had converted induced pluripotent stem cells (iPSCs) into kidney structures that resemble those from a normal human kidney.

Second, a team of Australian researchers lead by Dr. Minoru Takasato successfully grew nephron organoids from iPSCs, releasing their results in Nature.

It’s been quite a week. Happy Thursday!


Want to get this fun weekly update?  Join below and we’ll keep you in the loop, starting next week!

Filed Under: Adipose SCs, HSCs, iPS Cells, MSCs, Neural Stem Cells, Stem Cells Tagged With: 3 bullet thursday, bioprinting, iPSCs, market news, regenerative medicine, rooster bio

Guest Post: Role of the Physio-chemical Environment in Steering Stem Cell Differentiation

October 1, 2015 By Cade Hildreth (CEO) Leave a Comment

The role of the physio-chemical environment in steering stem cell differentiation

This guest post by JM Wilkinson and Kelly S. Davidge of Kirkstall Ltd. highlights an emerging technology, organotypic cell cultures.  


Cell culture has come a long way in the last 20 years. 3D is rapidly replacing 2D (plated cells on cover slips) and now perfusion based systems with gentle flow of media are improving proliferation rates, control of differentiation and cell function. For in vitro safety and efficacy testing the goal is organotypic behaviour where the cell metabolism accurately reflects what happens in the human body. However some of the techniques also have direct relevance for stem cell research too. In this note we discuss some of the important factors that help to steer stem cell differentiation and could deliver mature cells with low batch to batch variation and a far more homogeneous population. [Read more…]

Filed Under: iPS Cells, Stem Cells Tagged With: induced pluripotent stem cell differentiation, iPSC differentiation, Kirkstall Ltd, organotypic cell culture, Quasi Vivo, stem cell differentiation

Top 10 Most Shared Stem Cell Articles of the Past 12 Months

September 30, 2015 By Cade Hildreth (CEO) Leave a Comment

Top 10 Most Shared Stem Cell Articles of Past 12 Months

Social Analytics Reveal Key Findings about Stem Cell Article Popularity

The field of stem cell research has boomed over the past twelve months, bringing to light new ideas for treatments and applications. Here at BioInformant, we strive to do our best to provide you with the most up to date information related to the industry. As a supplement to our monthly round-ups, we thought it would be important to share the top ten most shared stem cell articles from the past year.
[Read more…]

Filed Under: HSCs, iPS Cells, MSCs, Neural Stem Cells, Stem Cells Tagged With: market research, metrics, social analytics, stem cell news, stem cells, top shared stem cell articles

Dr. Robert Lanza, Chief Scientific Officer of Ocata Therapeutics Honored as iPSC Industry Influencer by BioInformant

September 17, 2015 By Cade Hildreth (CEO) Leave a Comment

Dr. Robert Lanza, Chief Scientific Officer of Ocata Therapeutics Awarded the Honor of iPSC Industry Influencer

Recently, BioInformant released an article titled,  “Do You Know the Top 5 iPS Cell Influencers (Right Now)?” In it, we named the five most important thought leaders that are driving therapeutic and commercial progress with induced pluripotent stem cells (iPS cells) right now in 2015. One of the important individuals that we highlighted was Dr. Robert Lanza, Chief Scientific Officer of Ocata Therapeutics.

In response to this article, Ocata Therapeutics released a press release announcing that “Dr. Robert Lanza, Chief Scientific Officer of Ocata Therapeutics has been awarded the honor of iPSC industry influencer by BioInformant, a leading research firm serving the stem cell sector.” [Read more…]

Filed Under: iPS Cells, Press Releases, Stem Cells Tagged With: induced pluripotent stem cells, iPSC, iPSC industry influencer, Ocata Therapeutics, regenerative ophthalmology, Robert Lanza

  • « Previous Page
  • 1
  • …
  • 49
  • 50
  • 51
  • 52
  • 53
  • …
  • 56
  • Next Page »

Nanocellect

Marathon Products

Kimera Society

Let’s Get Social

  • Facebook
  • Twitter
  • LinkedIn
  • Pinterest
  • Instagram

Cart

Top Rated Products

  • Job Posting on BioInformant <Job Posting on BioInformant.com - Your Perfect Hire Is In Our Audience $297
  • U.S. Cord Blood Banking Survey <Cord Blood Banking Survey of U.S. Parents [2017] $197
  • Exosome Companies 2020 <Global Database of Exosome Companies $149 $97

Featured Posts

iPSC derived cell therapeutics

The Pipeline for iPSC-Derived Cell Therapeutics in 2022

Stem cell companies

List of Stem Cell Companies Worldwide (2022)

Feature | Exosome Companies | Exosome Companies | Tiny Exosomes, Enormous Potential

List of Exosome Companies: Tiny Packages, Enormous Potential

My Tweets

BioInformant's World-Class Clients

  • Submit Press Release
  • Advertise
  • Privacy and Terms

Copyright © 2022 · BIOINFORMANT, Your Global Leader in Stem Cell Market Research

| Email: [email protected] | Phone: 703-859-7617 |

800 Corporate Drive, Suite 301, Stafford, VA 22554, United States

Disclaimer: All statements made on this website are NOT expressed as medical claims or advice. They are not intended to diagnose, treat, cure or prevent any disease or condition. If you have a health condition or concern, consult your physician or health care provider.